Developmental outcome of extremely preterm infants is improved after less invasive surfactant application: Developmental outcome after LISA.
less invasive surfactant application
mental development index
neurodevelopment
preterm infants
psychomotor development index
Journal
Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
20
03
2020
revised:
16
07
2020
accepted:
31
08
2020
pubmed:
7
9
2020
medline:
15
5
2021
entrez:
6
9
2020
Statut:
ppublish
Résumé
The aim of this study was to evaluate neurocognitive outcome at 24 months of corrected age after less invasive surfactant application (LISA) in preterm infants born at 23-26 weeks of gestational age. Surviving participants of a LISA trial conducted in 13 German level III neonatal intensive care units were reviewed for assessment of developmental outcome, hearing and vision problems, growth and rehospitalisation days. Maternal depression, breastfeeding rates and socio-economic factors were evaluated as potentially confounding factors. In total, 156/182 infants took part in the study, 78 had received surfactant via LISA and 78 via endotracheal intubation. 22% of LISA infants compared to 42% of intubated infants had a psychomotor development index (PDI) <70 (0.012). A significant difference in mental development index (MDI) was observed in the stratum of more mature infants (25 and 26 weeks of GA). For this group, MDI < 70 was observed in 4% of LISA infants vs 21% of intubated infants (P = 0.008). At 24 months of age, the LISA-treated infants scored less often PDI < 70 and had similar results in MDI. Infants born at 25 and 26 weeks treated with LISA had lower rates of severe disability. LISA is safe and may be superior.
Substances chimiques
Pulmonary Surfactants
0
Surface-Active Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
818-825Informations de copyright
© 2020 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.
Références
Klotz D, Porcaro U, Fleck T, Fuchs H. European perspective on less invasive surfactant administration-a survey. Eur J Pediatr. 2017;176(2):147-154.
Aldana-Aguirre JC, Pinto M, Featherstone RM, Kumar M. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2017;102(1):F17-F23.
Isayama T, Iwami H, McDonald S, Beyene J. Association of noninvasive ventilation strategies with mortality and bronchopulmonary dysplasia among preterm infants: a systematic review and meta-analysis. JAMA. 2016;316(6):611-624.
Teig N, Weitkamper A, Rothermel J, et al. Observational Study on Less Invasive Surfactant Administration (LISA) in preterm infants<29 weeks-short and long-term outcomes. Z Geburtshilfe Neonatol. 2015;219(6):266-273.
Porath M, Korp L, Wendrich D, Dlugay V, Roth B, Kribs A. Surfactant in spontaneous breathing with nCPAP: neurodevelopmental outcome at early school age of infants </= 27 weeks. Acta Paediatr. 2011;100(3):352-359.
Marquez Isidro E, Sanchez Luna M, Ramos-Navarro C. Long-term outcomes of preterm infants treated with less invasive surfactant technique (LISA). J Matern Fetal Neonatal Med. 2019;12:1-6.
Kurepa D, Perveen S, Lipener Y, Kakkilaya V. The use of less invasive surfactant administration (LISA) in the United States with review of the literature. J Perinatol. 2019;39(3):426-432.
Twilhaar ES, de Kieviet JF, Aarnoudse-Moens CS, van Elburg RM, Oosterlaan J. Academic performance of children born preterm: a meta-analysis and meta-regression. Arch Dis Child Fetal Neonatal Ed. 2018;103(4):F322-F330.
Dekker J, Lopriore E, van Zanten HA, Tan R, Hooper SB, Te Pas AB. Sedation during minimal invasive surfactant therapy: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2019;104(4):F378-F383.
Kribs A, Roll C, Gopel W, et al. Nonintubated surfactant application vs conventional therapy in extremely preterm infants: a randomized clinical trial. JAMA Pediatr. 2015;169(8):723-730.
Walsh MC, Szefler S, Davis J, et al. Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics. 2006;117(3 Pt 2):S52-S56.
Bayley N. Bayley Scales of Infant and Toddler Development, 3rd edn. San Antonio, TX: Psychological Corporation; 2006.
Radloff LS. The use of the Center for Epidemiologic Studies Depression Scale in adolescents and young adults. J Youth Adolesc. 1991;20(2):149-166.
Fydrich TSG, Tydecks S, Brähler E. Fragebogen zur sozialen Unterstützung (F-SozU): Normierung der Kurzform (K-14). Z Med Psychol. 2009;18:43-48.
Patel RM. Short- and long-term outcomes for extremely preterm infants. Am J Perinatol. 2016;33(3):318-328.
Travers CP, Carlo WA, McDonald SA, et al. Mortality and pulmonary outcomes of extremely preterm infants exposed to antenatal corticosteroids. Am J Obstet Gynecol. 2018;218(1):130 e1-e13.
Watkins PL, Dagle JM, Bell EF, Colaizy TT. Outcomes at 18 to 22 months of corrected age for infants born at 22 to 25 weeks of gestation in a center practicing active management. J Pediatr. 2019;217:52-58.
Younge N, Goldstein RF, Cotten CM. Eunice Kennedy Shriver National Institute of Child H, Human Development Neonatal Research N. Survival and neurodevelopment of periviable infants. N Engl J Med. 2017;376(19):1890-1891.
Neri E, Agostini F, Baldoni F, Facondini E, Biasini A, Monti F. Preterm infant development, maternal distress and sensitivity: the influence of severity of birth weight. Early Human Dev. 2017;106-107:19-24.
Roze JC, Darmaun D, Boquien CY, et al. The apparent breastfeeding paradox in very preterm infants: relationship between breast feeding, early weight gain and neurodevelopment based on results from two cohorts, EPIPAGE and LIFT. BMJ Open. 2012;2(2):e000834.
Williams E, Dassios T, Arnold K, Hickey A, Greenough A. Prolonged ventilation and postnatal growth of preterm infants. J Perinat Med. 2019;48(1):82-86.
Kuint J, Lerner-Geva L, Chodick G, et al. Rehospitalization through childhood and adolescence: association with neonatal morbidities in infants of very low birth weight. J Pediatr. 2017;188:135-141.e2.
Herting E, Kribs A, Hartel C, et al. Two-year outcome data suggest that less invasive surfactant administration (LISA) is safe. Results from the follow-up of the randomized controlled AMV (avoid mechanical ventilation) study. Eur J Pediatr. 2020;179(8):1309-1313.
Vliegenthart RJS, van Kaam AH, Aarnoudse-Moens CSH, van Wassenaer AG, Onland W. Duration of mechanical ventilation and neurodevelopment in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2019;104(6):F631-F635.